Exact Mass: 544.3723472

Exact Mass Matches: 544.3723472

Found 88 metabolites which its exact mass value is equals to given mass value 544.3723472, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Ganoderic acid Mj

(2Z)-5-(acetyloxy)-6-{5-hydroxy-9-methoxy-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-14-yl}-2-methylhept-2-enoic acid

C33H52O6 (544.3763692)


Ganoderic acid Mj is found in mushrooms. Ganoderic acid Mj is a metabolite of Ganoderma lucidum (reishi Metabolite of Ganoderma lucidum (reishi). Ganoderic acid Mj is found in mushrooms.

   

Ganoderic acid Mi

(2Z)-6-[5-(acetyloxy)-12-hydroxy-9-methoxy-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-14-yl]-2-methylhept-2-enoic acid

C33H52O6 (544.3763692)


Ganoderic acid Mi is found in mushrooms. Ganoderic acid Mi is a metabolite of Ganoderma lucidum (reishi Metabolite of Ganoderma lucidum (reishi). Ganoderic acid Mi is found in mushrooms.

   

DG(8:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

(2S)-1-hydroxy-3-(octanoyloxy)propan-2-yl (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoate

C33H52O6 (544.3763692)


DG(8:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/8:0/0:0)

(2S)-3-hydroxy-2-(octanoyloxy)propyl (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoate

C33H52O6 (544.3763692)


DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C33H52O6 (544.3763692)


DG(8:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C33H52O6 (544.3763692)


DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C33H52O6 (544.3763692)


DG(8:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C33H52O6 (544.3763692)


DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C33H52O6 (544.3763692)


DG(8:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C33H52O6 (544.3763692)


DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (4Z,7Z,10Z,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C33H52O6 (544.3763692)


DG(8:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/8:0/0:0)

(2S)-3-hydroxy-2-(octanoyloxy)propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C33H52O6 (544.3763692)


DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

(2R)-2-hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C33H52O6 (544.3763692)


DG(8:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/8:0)

(2S)-2-hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C33H52O6 (544.3763692)


DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C33H52O6 (544.3763692)


DG(8:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C33H52O6 (544.3763692)


DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C33H52O6 (544.3763692)


DG(8:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C33H52O6 (544.3763692)


DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C33H52O6 (544.3763692)


DG(8:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C33H52O6 (544.3763692)


DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C33H52O6 (544.3763692)


DG(8:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C33H52O6 (544.3763692)


DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

3-Hydroxyisorenieratene

3-Hydroxyisorenieratene

C40H48O (544.3704958)


   

Methyl 2-acetyltormentate

Methyl 2-acetyltormentate

C33H52O6 (544.3763692)


   

22-Acetoxy-3alpha-hydroxy-7alpha-methoxylanosta-8,24E-dien-26-oic acid

22-Acetoxy-3alpha-hydroxy-7alpha-methoxylanosta-8,24E-dien-26-oic acid

C33H52O6 (544.3763692)


   

16beta-methoxyalisol B 23-acetate|16beta-Methoxyalisol B monoacetate

16beta-methoxyalisol B 23-acetate|16beta-Methoxyalisol B monoacetate

C33H52O6 (544.3763692)


   

3alpha-acetoxy-21R-methoxy-17alpha-20S-21,23R-epoxyapotirucall-14,25-dien-7alpha,24R-diol|chisopanin C

3alpha-acetoxy-21R-methoxy-17alpha-20S-21,23R-epoxyapotirucall-14,25-dien-7alpha,24R-diol|chisopanin C

C33H52O6 (544.3763692)


   
   

3beta-acetoxy-12beta-methoxy-7,8-dihydroholothurinogenin

3beta-acetoxy-12beta-methoxy-7,8-dihydroholothurinogenin

C33H52O6 (544.3763692)


   

methyl tormentate-3-acetate

methyl tormentate-3-acetate

C33H52O6 (544.3763692)


   
   

23-acetoxyimberbic acid 29-methyl ester

23-acetoxyimberbic acid 29-methyl ester

C33H52O6 (544.3763692)


   

phyllofoliaspongin

phyllofoliaspongin

C33H52O6 (544.3763692)


   

(2alpha,3alpha)-2,29-dihydroxy-3,23-[(1,1-dimethylmethylene)dioxy]olean-12-en-28-oic acid|stachlic acid B

(2alpha,3alpha)-2,29-dihydroxy-3,23-[(1,1-dimethylmethylene)dioxy]olean-12-en-28-oic acid|stachlic acid B

C33H52O6 (544.3763692)


   

cavalerol J|methyl (3beta,6beta,11beta,17epsilon,21beta)-6-(acetyloxy)-3,11-dihydroxyhop-22(29)-en-24-oate|methyl 6beta-(acetyloxy)-3beta,11beta-dihydroxy-21alphaH-hop-22(29)-en-24-oate

cavalerol J|methyl (3beta,6beta,11beta,17epsilon,21beta)-6-(acetyloxy)-3,11-dihydroxyhop-22(29)-en-24-oate|methyl 6beta-(acetyloxy)-3beta,11beta-dihydroxy-21alphaH-hop-22(29)-en-24-oate

C33H52O6 (544.3763692)


   

2-Ac,Me ester-2,3,23-(2alpha,3beta)-Trihydroxy-12-oleanen-28-oic acid

2-Ac,Me ester-2,3,23-(2alpha,3beta)-Trihydroxy-12-oleanen-28-oic acid

C33H52O6 (544.3763692)


   

2alpha-acetoxy-3beta,24-epoxy-3alpha-hydroxy-D:A-friedooleanan-29-oic acid methyl ester

2alpha-acetoxy-3beta,24-epoxy-3alpha-hydroxy-D:A-friedooleanan-29-oic acid methyl ester

C33H52O6 (544.3763692)


   

methyl 2-acetylasiatate

methyl 2-acetylasiatate

C33H52O6 (544.3763692)


   

11α-Hemiglutaryloxy-1,25-dihydroxyvitamin D3

(5Z,7E)-(1S,3R,11R)-11-hemiglutaryloxy-9,10-seco-5,7,10(19)-cholestatrien-1,3,25-triol

C33H52O6 (544.3763692)


   

Ganoderic acid Mi

(2Z)-6-[5-(acetyloxy)-12-hydroxy-9-methoxy-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-14-yl]-2-methylhept-2-enoic acid

C33H52O6 (544.3763692)


   

Ganoderic acid Mj

(2Z)-5-(acetyloxy)-6-{5-hydroxy-9-methoxy-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-14-yl}-2-methylhept-2-enoic acid

C33H52O6 (544.3763692)


   

11alpha-Hemiglutaryloxy-1,25-dihydroxyvitamin D3

(5Z,7E)-(1S,3R,11R)-11-hemiglutaryloxy-9,10-seco-5,7,10(19)-cholestatrien-1,3,25-triol

C33H52O6 (544.3763692)


   

18-Hydroxyrenierapurpurin

18-Hydroxyrenierapurpurin

C40H48O (544.3704958)


   

DG(8:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

DG(8:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

C33H52O6 (544.3763692)


   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/8:0/0:0)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/8:0/0:0)

C33H52O6 (544.3763692)


   

DG(8:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

DG(8:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C33H52O6 (544.3763692)


   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/8:0)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/8:0)

C33H52O6 (544.3763692)


   

DG(8:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

DG(8:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

C33H52O6 (544.3763692)


   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/8:0/0:0)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/8:0/0:0)

C33H52O6 (544.3763692)


   

DG(8:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

DG(8:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C33H52O6 (544.3763692)


   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/8:0)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/8:0)

C33H52O6 (544.3763692)


   

DG(8:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

DG(8:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

C33H52O6 (544.3763692)


   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/8:0/0:0)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/8:0/0:0)

C33H52O6 (544.3763692)


   

DG(8:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

DG(8:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C33H52O6 (544.3763692)


   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/8:0)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/8:0)

C33H52O6 (544.3763692)


   

DG(8:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

DG(8:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

C33H52O6 (544.3763692)


   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/8:0/0:0)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/8:0/0:0)

C33H52O6 (544.3763692)


   

DG(8:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

DG(8:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C33H52O6 (544.3763692)


   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/8:0)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/8:0)

C33H52O6 (544.3763692)


   

DG(8:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

DG(8:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

C33H52O6 (544.3763692)


   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/8:0/0:0)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/8:0/0:0)

C33H52O6 (544.3763692)


   

DG(8:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

DG(8:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C33H52O6 (544.3763692)


   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/8:0)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/8:0)

C33H52O6 (544.3763692)


   

N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C30H48N4O5 (544.3624517999999)


   

1-cyclohexyl-3-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

1-cyclohexyl-3-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C30H48N4O5 (544.3624517999999)


   

N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C30H48N4O5 (544.3624517999999)


   

N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C30H48N4O5 (544.3624517999999)


   

N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C30H48N4O5 (544.3624517999999)


   

N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C30H48N4O5 (544.3624517999999)


   
   
   
   

[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxyheptadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxyheptadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C28H53N2O6P (544.3641048)


   

[(4E,8E,12E)-3-hydroxy-2-(octanoylamino)pentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E,12E)-3-hydroxy-2-(octanoylamino)pentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C28H53N2O6P (544.3641048)


   

[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)octadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)octadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C28H53N2O6P (544.3641048)


   

[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)icosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)icosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C28H53N2O6P (544.3641048)


   

[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxyhexadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxyhexadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C28H53N2O6P (544.3641048)


   

[(4E,8E,12E)-2-acetamido-3-hydroxyhenicosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E,12E)-2-acetamido-3-hydroxyhenicosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C28H53N2O6P (544.3641048)


   

[(4E,8E,12E)-2-(butanoylamino)-3-hydroxynonadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E,12E)-2-(butanoylamino)-3-hydroxynonadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C28H53N2O6P (544.3641048)


   

[(4E,8E,12E)-3-hydroxy-2-(nonanoylamino)tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E,12E)-3-hydroxy-2-(nonanoylamino)tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C28H53N2O6P (544.3641048)


   

[1-carboxy-3-[3-[(7E,9E,11E,13E,15E,17E,19E)-docosa-7,9,11,13,15,17,19-heptaenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(7E,9E,11E,13E,15E,17E,19E)-docosa-7,9,11,13,15,17,19-heptaenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

C32H50NO6+ (544.3637940000001)


   

TG(30:5)

TG(6:0_10:4_14:1)

C33H52O6 (544.3763692)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   

methyl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-11-(acetyloxy)-1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

methyl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-11-(acetyloxy)-1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C33H52O6 (544.3763692)


   

(2z)-5-(acetyloxy)-6-{7-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enoic acid

(2z)-5-(acetyloxy)-6-{7-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enoic acid

C33H52O6 (544.3763692)


   

1-(3,3-dimethyloxiran-2-yl)-3-{10-hydroxy-2-methoxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}butyl acetate

1-(3,3-dimethyloxiran-2-yl)-3-{10-hydroxy-2-methoxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}butyl acetate

C33H52O6 (544.3763692)


   

(2r)-3-{[(2s,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-n-[(9z)-heptadec-9-en-1-yl]-2-hydroxypropanimidic acid

(2r)-3-{[(2s,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-n-[(9z)-heptadec-9-en-1-yl]-2-hydroxypropanimidic acid

C28H52N2O8 (544.3723472)